Integrative oncology practice guidelines

Journal of the Society for Integrative Oncology

Volumn 5, Issue 2, 2007, Pages 65-84

  Deng, Gary E ^a   Cassileth, Barrie R ^a,i   Cohen, Lorenzo ^b   Gubili, Jyothirmai ^a   Johnstone, Peter A S ^c   Kumar, Nagi ^d   Vickers, Andrew ^a   Abrams, Donald ^e   Rosenthal, David ^f   Sagar, Stephen ^g   Tripathy, Debu ^h   Ponesse, Loretta A ⁱ  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g JURAVINSKI CANCER CENTRE   (Canada)

^h University of Texas Southwestern   (United States)

ⁱ Center for Bio Medical Communication Inc   (United States)

Author keywords

CAM; Cancer; Complementary therapies; Integrative medicine; Oncology

Indexed keywords

PEMETREXED;

ACUPUNCTURE; ALTERNATIVE MEDICINE; CANCER; CANCER PATIENT; CLINICAL TRIAL; DIET SUPPLEMENTATION; DISEASE CONTROL; DRUG MEGADOSE; ELECTROSTIMULATION THERAPY; HERBAL MEDICINE; HUMAN; INTEGRATIVE MEDICINE; MEDICAL PRACTICE; META ANALYSIS; ONCOLOGY; PRACTICE GUIDELINE; REVIEW; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW;

ACUPUNCTURE; COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; HUMANS; NEOPLASMS; PRACTICE GUIDELINES; PSYCHOPHYSIOLOGY;

EID: 34447578631     PISSN: 1715894X     EISSN: None     Source Type: Journal    
DOI: 10.2310/7200.2007.002     Document Type: Review

References (153)

1. Deng G, Cassileth BR, Yeung KS. Complementary therapies for cancer-related symptoms. J Support Oncol 2004;2:419-26, discussion 427-9.
2. Cassileth BR, Deng G. Complementary and alternative therapies for cancer. Oncologist 2004;9:80-9.
3. Cassileth B, Deng G, Vickers A, et al. PDQ integrative oncology. Hamilton (ON): BC Decker; 2005.
4. Barnes PM, Powell-Griner E, McFann K, et al. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004;1-19.
5. Adams J, Sibbritt DW, Easthope G, et al. The profile of women who consult alternative health practitioners in Australia. Med J Aust 2003;179:297-300.
6. Chrystal K, Allan S, Forgeson G, et al. The use of complementary/ alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. N Z Med J 2003;116:U296.
7. Lee MM, Chang JS, Jacobs B, et al. Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations. Am J Public Health 2002;92:1606-9.
8. Weiger WA, Smith M, Boon H, et al. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 2002;137:889-903.
9. Navo MA, Phan J, Vaughan C, et al. An assessment of the utilization of complementary alternative medication in women with gynecologic or breast malignancies. J Clin Oncol 2004;22:671-7.
10. Richardson MA, Sanders T, Palmer JL, et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505-14.
11. Exploring complementary and alternative medicine. In: Medicine Io, editor. The Richard and Hinda Rosenthal Lectures 2001. Washington (DC): The National Academies Press; 2003.
12. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 1998;83:777-82.
13. Hyodo I, Amano N, Eguchi K, et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 2005;23:2645-54.
14. Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005;16:655-63.
15. Sovak M, Seligson AL, Konas M, et al. Herbal composition PC-SPES for management of prostate cancer: identification of active principles. J Natl Cancer Inst 2002;94:1275-81.
16. Beijnen JH, Schellens JH. Drug interactions in oncology. Lancet Oncol 2004;5:489-96.
17. Sparreboom A, Cox MC, Acharya MR, et al. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 2004;22:2489-503.
18. Albanes D, Heinonen OP, Taylor PR, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70.
19. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029-35.
20. Cohen MH, Eisenberg DM. Potential physician malpractice liability associated with complementary and integrative medical therapies. Ann Intern Med 2002;136:596-603.
21. Frenkel M, Ben-Arye E, Baldwin CD, et al. Approach to communicating with patients about the use of nutritional supplements in cancer care. South Med J 2005;98:289-94.
22. Wolsko PM, Eisenberg DM, Davis RB, et al. Use of mind-body medical therapies. J Gen Intern Med 2004;19:43-50.
23. Devine EC, Westlake SK. The effects of psychoeducational care provided to adults with cancer: meta-analysis of 116 studies. Oncol Nurs Forum 1995;22:1369-81.
24. Astin JA. Mind-body therapies for the management of pain. Clin J Pain 2004;20:27-32.
25. Newell SA, Sanson-Fisher RW, Savolainen NJ. Systematic review of psychological therapies for cancer patients: overview and recommendations for future research. J Natl Cancer Inst 2002;94:558-84.
26. Shapiro SL, Bootzin RR, Figueredo AJ, et al. The efficacy of mindfulness-based stress reduction in the treatment of sleep disturbance in women with breast cancer: an exploratory study. J Psychosom Res 2003;54:85-91.
27. Speca M, Carlson LE, Goodey E, et al. A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 2000;62:613-22.
28. Carlson LE, Speca M, Patel KD, et al. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 2004;29:448-74.
29. Cohen L, Warneke C, Fouladi RT, et al. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 2004;100:2253-60.
30. Mustian KM, Katula JA, Zhao H. A pilot study to assess the influence of tai chi chuan on functional capacity among breast cancer survivors. J Support Oncol 2006;4:139-45.
31. Mustian KM, Katula JA, Gill DL, et al. Tai chi chuan, health-related quality of life and self-esteem: a randomized trial with breast cancer survivors. Support Care Cancer 2004;12:871-6.
32. Montgomery GH, Weltz CR, Seltz M, et al. Brief presurgery hypnosis reduces distress and pain in excisional breast biopsy patients. Int J Clin Exp Hypn 2002;50:17-32.
33. Liossi C, Hatira P. Clinical hypnosis versus cognitive behavioral training for pain management with pediatric cancer patients undergoing bone marrow aspirations. Int J Clin Exp Hypn 1999;47:104-16.
34. Faymonville ME, Mambourg PH, Joris J, et al. Psychological approaches during conscious sedation. Hypnosis versus stress reducing strategies: a prospective randomized study. Pain 1997;73:361-7.
35. Syrjala KL, Cummings C, Donaldson GW. Hypnosis or cognitive behavioral training for the reduction of pain and nausea during cancer treatment: a controlled clinical trial. Pain 1992;48:137-46.
36. Integration of behavioral and relaxation approaches into the treatment of chronic pain and insomnia. NIH Technology Assessment Panel on Integration of Behavioral and Relaxation Approaches into the Treatment of Chronic Pain and Insomnia. JAMA 1996;276:313-3.
37. Zeltzer LK, Dolgin MJ, LeBaron S, et al. A randomized, controlled study of behavioral intervention for chemotherapy distress in children with cancer. Pediatrics 1991;88:34-42.
38. Morrow GR, Morrell C. Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy. N Engl J Med 1982;307:1476-80.
39. Holland JC, Morrow GR, Schmale A, et al. A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol 1991;9:1004-11.
40. Decker TW, Cline-Elsen J, Gallagher M. Relaxation therapy as an adjunct in radiation oncology. J Clin Psychol 1992;48:388-93.
41. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 1994;151:1172-80.
42. Frank JM. The effects of music therapy and guided visual imagery on chemotherapy induced nausea and vomiting. Oncol Nurs Forum 1985;12:47-52.
43. Sabo CE, Michael SR. The influence of personal message with music on anxiety and side effects associated with chemotherapy. Cancer Nurs 1996;19:283-9.
44. Boldt S. The effects of music therapy on motivation, psychological well-being, physical comfort, and exercise endurance of bone marrow transplant patients. J Music Ther 1996;33:164-88.
45. Burns SJ, Harbuz MS, Hucklebridge F, et al. A pilot study into the therapeutic effects of music therapy at a cancer help center. Altern Ther Health Med 2001;7:48-56.
46. Ahles TA, Tope DM, Pinkson B, et al. Massage therapy for patients undergoing autologous bone marrow transplantation. J Pain Symptom Manage 1999;18:157-63.
47. Stephenson NL, Weinrich SP, Tavakoli AS. The effects of foot reflexology on anxiety and pain in patients with breast and lung cancer. Oncol Nurs Forum 2000;27:67-72.
48. Grealish L, Lomasney A, Whiteman B. Foot massage. A nursing intervention to modify the distressing symptoms of pain and nausea in patients hospitalized with cancer. Cancer Nurs 2000;23:237-43.
49. Wilkinson S, Aldridge J, Salmon I, et al. An evaluation of aromatherapy massage in palliative care. Palliat Med 1999;13:409-17.
50. Taylor AG, Galper DI, Taylor P, et al. Effects of adjunctive Swedish massage and vibration therapy on short-term post-operative outcomes: a randomized, controlled trial. J Altern Complement Med 2003;9:77-89.
51. Post-White J, Kinney ME, Savik K, et al. Therapeutic massage and healing touch improve symptoms in cancer. Integr Cancer Ther 2003;2:332-44.
52. Ballard CG, O'Brien JT, Reichelt K, et al. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry 2002;63:553-8.
53. Graham PH, Browne L, Cox H, et al. Inhalation aromatherapy during radiotherapy: results of a placebo-controlled double-blind randomized trial. J Clin Oncol 2003;21:2372-6.
54. Soden K, Vincent K, Craske S, et al. A randomized controlled trial of aromatherapy massage in a hospice setting. Palliat Med 2004;18:87-92.
55. Gedney JJ, Glover TL, Fillingim RB. Sensory and affective pain discrimination after inhalation of essential oils. Psychosom Med 2004;66:599-606.
56. Cherkin DC, Sherman KJ, Deyo RA, et al. A review of the evidence for the effectiveness, safety, and cost of acupuncture, massage therapy, and spinal manipulation for back pain. Ann Intern Med 2003;138:898-906.
57. Ernst E. The safety of massage therapy. Rheumatology (Oxford) 2003;42:1101-6.
58. Cook CA, Guerrerio JF, Slater VE. Healing touch and quality of life in women receiving radiation treatment for cancer: a randomized controlled trial. Altern Ther Health Med 2004;10:34-41.
59. Meltz ML. Radiofrequency exposure and mammalian cell toxicity, genotoxicity, and transformation. Bioelectromagnetics Suppl 2003;6:S196-213.
60. Elwood JM. Epidemiological studies of radio frequency exposures and human cancer. Bioelectromagnetics Suppl 2003;6:S63-73.
61. Kheifets LI. Electric and magnetic field exposure and brain cancer: a review. Bioelectromagnetics Suppl 2001;5:S120-31.
62. Han JS. Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies. Trends Neurosci 2003;26:17-22.
63. Wu MT, Hsieh JC, Xiong J, et al. Central nervous pathway for acupuncture stimulation: localization of processing with functional MR imaging of the brain - preliminary experience. Radiology 1999;212:133-41.
64. NIH Consensus Conference. Acupuncture. JAMA 1998;280:1518-24.
65. Mdchart D, Linde K, Fischer P, et al. Acupuncture for recurrent headaches: a systematic review of randomized controlled trials. Cephalalgia 1999;19:779-86; discussion 765.
66. Berman BM, Lao L, Langenberg P, et al. Effectiveness of acupuncture as adjunctive therapy in osteoarthritis of the knee: a randomized, controlled trial. Ann Intern Med 2004;141:901-10.
67. White P, Lewith G, Prescott P, et al. Acupuncture versus placebo for the treatment of chronic mechanical neck pain: a randomized, controlled trial. Ann Intern Med 2004;141:911-9.
68. Manheimer E, White A, Berman B, et al. Meta-analysis: acupuncture for low back pain. Ann Intern Med 2005;142:651-63.
69. Alimi D, Rubino C, Pichard-Leandri E, et al. Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol 2003;21:4120-6.
70. Zhang WT, Jin Z, Cui GH, et al. Relations between brain network activation and analgesic effect induced by low vs. high frequency electrical acupoint stimulation in different subjects: a functional magnetic resonance imaging study. Brain Res 2003;982:168-78.
71. Johnstone PA, Niemtzow RC, Riffenburgh RH. Acupuncture for xerostomia: clinical update. Cancer 2002;94:1151-6.
72. Johnstone PA, Peng YP, May BC, et al. Acupuncture for pilocarpine-resistant xerostomia following radiotherapy for head and neck malignancies. Int J Radiat Oncol Biol Phys 2001;50:353-7.
73. Johnstone PA, Polston GR, Niemtzow RC, et al. Integration of acupuncture into the oncology clinic. Palliat Med 2002;16:235-9.
74. Blom M, Lundeberg T. Long-term follow-up of patients treated with acupuncture for xerostomia and the influence of additional treatment. Oral Dis 2000;6:15-24.
75. Rydholm M, Strang P. Acupuncture for patients in hospital-based home care suffering from xerostomia. J Palliat Care 1999;15:20-3.
76. Dawidson I, Angmar-Mansson B, Blom M, et al. Sensory stimulation (acupuncture) increases the release of calcitonin gene-related peptide in the saliva of xerostomia sufferers. Neuropeptides 1999;33:244-50.
77. Dawidson I, Angmar-Mansson B, Blom M, et al. Sensory stimulation (acupuncture) increases the release of vasoactive intestinal polypeptide in the saliva of xerostomia sufferers. Neuropeptides 1998;32:543-8.
78. Andersen SW, Machin D. Acupuncture treatment of patients with radiation-induced xerostomia. Oral Oncol 1997;33:146-7.
79. Blom M, Dawidson I, Fernberg JO, et al. Acupuncture treatment of patients with radiation-induced xerostomia. Eur J Cancer B Oral Oncol 1996;32B:182-90.
80. Lee A, Done ML. Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev 2004;CD003281.
81. Shen J, Wenger N, Glaspy J, et al. Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial. JAMA 2000;284:2755-61.
82. Josefson A, Kreuter M. Acupuncture to reduce nausea during chemotherapy treatment of rheumatic diseases. Rheumatology (Oxford) 2003;42:1149-54.
83. Streitberger K, Friedrich-Rust M, Bardenheuer H, et al. Effect of acupuncture compared with placebo-acupuncture at P6 as additional antiemetic prophylaxis in high-dose chemotherapy and autologous peripheral blood stem cell transplantation: a randomized controlled single-blind trial. Clin Cancer Res 2003;9:2538-44.
84. Rosen T, de Veciana M, Miller HS, et al. A randomized controlled trial of nerve stimulation for relief of nausea and vomiting in pregnancy. Obstet Gynecol 2003;102:129-35.
85. Streitberger K, Diefenbacher M, Bauer A, et al. Acupuncture compared to placebo-acupuncture for postoperative nausea and vomiting prophylaxis: a randomised placebo-controlled patient and observer blind trial. Anaesthesia 2004;59:142-9.
86. Bertolucci LE, DiDario B. Efficacy of a portable acustimulation device in controlling seasickness. Aviat Space Environ Med 1995;66:1155-8.
87. Ming JL, Kuo BI, Lin JG, et al. The efficacy of acupressure to prevent nausea and vomiting in post-operative patients. J Adv Nurs 2002;39:343-51.
88. Gan TJ, Jiao KR, Zenn M, et al. A randomized controlled comparison of electro-acupoint stimulation or ondansetron versus placebo for the prevention of postoperative nausea and vomiting. Anesth Analg 2004;99:1070-5.
89. Roscoe JA, Morrow GR, Hickok JT, et al. The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study. J Pain Symptom Manage 2003;26:731-12.
90. White AR, Rampes H, Ernst E. Acupuncture for smoking cessation. Cochrane Database Syst Rev 2002;CD000009.
91. Bier ID, Wilson J, Studt P, et al. Auricular acupuncture education, and smoking cessation: a randomized, sham-controlled trial. Am J Public Health 2002;92:1642-7.
92. Domino EF, Ni L, Xu Y, et al. Regional cerebral blood flow and plasma nicotine after smoking tobacco cigarettes. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:319-27.
93. Filshie J, Penn K, Ashley S, et al. Acupuncture for the relief of cancer-related breathlessness. Palliat Med 1996;10:145-50.
94. Vickers AJ, Feinstein MB, Deng GE, et al. Acupuncture for dyspnea in advanced cancer: a randomized, placebo-controlled pilot trial [ISRCTN89462491]. BMC Palliat Care 2005;4:5.
95. Mock V, Atkinson A, Barsevick A, et al. NCCN practice guidelines for cancer-related fatigue. Oncology (Huntingt) 2000;14:151-61.
96. Vickers AJ, Straus DJ, Fearon B, et al. Acupuncture for postchemotherapy fatigue: a phase II study. J Clin Oncol 2004;22:1731-5.
97. Escalante CP, Grover T, Johnson BA, et al. A fatigue clinic in a comprehensive cancer center: design and experiences. Cancer 2001;92:1708-13.
98. Shlay JC, Chaloner K, Max MB, et al. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. JAMA 1998;280:1590-5.
99. Abuaisha BB, Costanzi JB, Boulton AJ. Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract 1998;39:115-21.
100. Wong R, Sagar S. Acupuncture treatment for chemotherapy-induced peripheral neuropathy - a case series. Acupunct Med 2006;24:87-91.
101. Melchart D, Weidenhammer W, Streng A, et al. Prospective investigation of adverse effects of acupuncture in 97 733 patients. Arch Intern Med 2004;164:104-5.
102. Hebert JR, Hurley TG, Ma Y. The effect of dietary exposures on recurrence and mortality in early stage breast cancer. Breast Cancer Res Treat 1998;51:17-28.
103. Holmes MD, Stampfer MJ, Colditz GA, et al. Dietary factors and the survival of women with breast carcinoma. Cancer 1999;86:826-35.
104. Davies AA, Davey Smith G, Harbord R, et al. Nutritional interventions and outcome in patients with cancer or preinvasive lesions: systematic review. J Natl Cancer Inst 2006;98:961-73.
105. Kumar NB, Hopkins K, Allen K, et al. Use of complementary/integrative nutritional therapies during cancer treatment: implications in clinical practice. Cancer Control 2002;9:236-43.
106. Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology (Williston Park) 1999;13:1003-8; discussion 1008, 1011-2.
107. Seifried HE, McDonald SS, Anderson DE, et al. The antioxidant conundrum in cancer. Cancer Res 2003;63:4295-8.
108. Kumar NB, Allen K, Bell H. Perioperative herbal supplement use in cancer patients: potential implications and recommendations for presurgical screening. Cancer Control 2005;12:149-57.
109. Ko RJ. A U.S. perspective on the adverse reactions from traditional Chinese medicines. J Chin Med Assoc 2004;67:109-16.
110. Cassileth B, Lucarelli C. Herb-drug interactions in oncology. Hamilton (ON): BC Decker; 2003.
111. Cohen I, Tagliaferri M, Tripathy D. Traditional Chinese medicine in the treatment of breast cancer. Semin Oncol 2002;29:563-74.
112. Vickers A. Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest 2002;20:1069-79.
113. Kodama N, Harada N, Nanba H. A polysaccharide, extract from Grifola frondosa, induces Th-1 dominant responses in carcinoma-bearing BALB/c mice. Jpn J Pharmacol 2002;90:357-60.
114. Ooi VE, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 2000;7:715-29.
115. Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 1999;19:65-96.
116. Taylor JA, Weber W, Standish L, et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA 2003;290:2824-30.
117. Yale SH, Liu K. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 2004;164:1237-41.
118. Barrett BP, Brown RL, Locken K, et al. Treatment of the common cold with unrefined echinacea. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2002;137:939-46.
119. Turner RB, Bauer R, Woelkart K, et al. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med 2005;353:341-8.
120. Blumenthal M, Farnsworth NR. Echinacea angustifolia in rhinovirus infections. N Engl J Med 2005;353:1971-2; author reply 1971-2.
121. Geier FP, Konstantinowicz T. Kava treatment in patients with anxiety. Phytother Res 2004;18:297-300.
122. Lehrl S. Clinical efficacy of kava extract WS 1490 in sleep disturbances associated with anxiety disorders. Results of a multicenter, randomized, placebo-controlled, double-blind clinical trial. J Affect Disord 2004;78:101-10.
123. Centers for Disease Control and Prevention. Hepatic toxicity possibly associated with kava-containing products - United States, Germany, and Switzerland, 1999-2002. JAMA 2003;289:36-7.
124. Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Ther 2004;76:428-40.
125. Linde K, Mulrow CD. St John's wort for depression. Cochrane Database Syst Rev 2000;CD000448.
126. Schrader E. Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression. Int Clin Psychopharmacol 2000;15:61-8.
127. Mathijssen RH, Verweij J, de Bruijn P, et al. Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst 2002;94:1247-9.
128. Markowitz JS, Donovan JL, DeVane CL, et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003;290:1500-4.
129. Kane GC, Lipsky JJ. Drug-grapefruit juice interactions. Mayo Clin Proc 2000;75:933-42.
130. Bailey DG, Dresser GK. Interactions between grapefruit juice and cardiovascular drugs. Am J Cardiovasc Drugs 2004;4:281-97.
131. Bailey DG, Spence JD, Edgar B, et al. Ethanol enhances the hemodynamic effects of fdodipine. Clin Invest Med 1989;12:357-62.
132. Memorial Sloan-Kettering Cancer Center, Available at: http://www.mskcc.org/aboutherbs (accessed March 16, 2007).
133. Vickers A. Alternative cancer cures: "unproven" or "disproven"? CA Cancer J Clin 2004;54:110-8.
134. Creagan ET, Moertel CG, O'Fallon JR, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 1979;301:687-90.
135. Moertd CG, Fleming TR, Creagan ET, et al. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med 1985;312:137-41.
136. Loprinzi CL, Levitt R, Barton DL, et al. Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial. Cancer 2005;104:176-82.
137. Kosty MP, Fleishman SB, Herndon JE II, et al. Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B. J Clin Oncol 1994;12:1113-20.
138. Kosty MP, Herndon JE, II, Green MR, et al. Placebo-controlled randomized study of hydrazine sulfate in lung cancer. J Clin Oncol 1995;13:1529-30.
139. Loprinzi CL, Goldberg RM, Su JQ, et al. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. J Clin Oncol 1994;12:1126-9.
140. Loprinzi CL, Kuross SA, O'Fallon JR, et al. Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. J Clin Oncol 1994;12:1121-5.
141. Goebell PJ, Otto T, Suhr J, et al. Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial. J Urol 2002;168:72-5.
142. Kleeberg UR, Suciu S, Brocker EB, et al. Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis. Eur J Cancer 2004;40:390-402.
143. Lenartz D, Dott U, Menzel J, et al. Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe. Anticancer Res 2000;20:2073-6.
144. Steuer-Vogt MK, Bonkowsky V, Ambrosch P, et al. The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial. Eur J Cancer 2001;37:23-31.
145. Bar-Sela G, Goldberg H, Beck D, et al. Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract. Anticancer Res 2006;26:709-13.
146. Grossarth-Maticek R, Kiene H, Baumgartner SM, et al. Use of Iscador, an extract of European misdetoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern Ther Health Med 2001;7:57-66, 68-72, 74-6 passim.
147. Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy. Italian Study Group for the Di Bella Multitherapy Trials. BMJ 1999;318:224-8.
148. Buiatti E, Arniani S, Verdecchia A, et al. Results from a historical survey of the survival of cancer patients given Di Bella multitherapy. Cancer 1999;86:2143-9.
149. Buckner JC, Malkin MG, Reed E, et al. Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma. Mayo Clin Proc 1999;74:137-45.
150. Cassileth BR, Lusk EJ, Guerry D, et al. Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med 1991;324:1180-5.
151. Moertel CG, Fleming TR, Rubin J, et al. A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med 1982;306:201-6.
152. Block JB, Serpick AA, Miller W, et al. Early clinical studies with lapachol (NSC-11905). Cancer Chemother Rep 1974;2 4:27-8.
153. Risberg T, Vickers A, Bremnes RM, et al. Does use of alternative medicine predict survival from cancer? Eur J Cancer 2003;39:372-7.